ORMP insider trading
NasdaqCM HealthcareORAMED PHARMACEUTICALS INC.: insider trade history from SEC Form 4 filings.
About ORAMED PHARMACEUTICALS INC.
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions with a technology platform for the oral delivery of therapeutic proteins. It develops ORMD-0801, an oral insulin capsule, which is in phase III clinical trial for the treatment of individuals with diabetes. The company has license agreements with Oravax Medical Inc. to commercialize oral vaccines for COVID-19 and other novel coronaviruses. Oramed Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in New York, New York.
Company website: www.oramed.com
ORMP insider activity at a glance
FilingIQ tracks 230 insider transactions for ORMP in filings since Feb 25, 2015. The most recent transaction is dated Oct 1, 2026.
Across the full history, 31 open-market purchases
and 22 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on ORMP insider trades is 52.9/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest ORMP Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Politicians who have traded ORMP
Frequently asked
- How many insider trades does FilingIQ track for ORMP?
- FilingIQ tracks 230 Form 4 insider transactions for ORMP (ORAMED PHARMACEUTICALS INC.), covering filings from Feb 25, 2015 onwards. 9 of those are dated within the last 90 days.
- Are ORMP insiders net buyers or net sellers?
- Across the full Form 4 history for ORMP, 31 transactions (13%) were open-market purchases and 22 (10%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does ORMP insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
- What sector is ORMP in?
- ORAMED PHARMACEUTICALS INC. (ORMP) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $132.45M.
Methodology & sources
Every ORMP insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.